Omnicell Achieves Record Revenues And Earnings In 2013

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

MOUNTAIN VIEW, Calif., Feb. 4, 2014 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions to healthcare systems, today announced results for its fourth quarter and year ended December 31, 2013.

GAAP results: Revenue for the fourth quarter of 2013 was $105.8 million, up $11.7 million or 12.5% from the third quarter of 2013, and up $15.6 million or 17.3% from the fourth quarter of 2012.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC